Acrx stock forecast.

ACRX Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq | ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list After Hours Last Updated: Sep 8, 2023 7:09 p.m. EDT Delayed...AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $1.20 per share a year ago. These ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.Nov 3, 2023 · ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list Alert NEW Dec 31, 2021 · ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.

AcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. 1.Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ACRX stock stock is $4.63, which predicts an increase of …Acurx Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...

Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $1.20 per share a year ago. These ...

Weather forecast 15 days - Gold Coast. 15:0023°26 km/h, 16:0023°25 km/h, 18 :0022°25 km/h, 21:0021°23 km/h, Hourly forecast Current weather conditions Gold Coast. Weather forecast forGold Coast, Queensland (Australia) ...Nov 29, 2023 · The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period. If you’re looking for penny stocks to buy right now, analysts may be a point of focus....AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 10,2023. AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises ...Share $0.69 After Hours: $0.75 (9.34%) +0.064 Closed: Nov 29, 4:02:05 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Trevena Inc $0.58 TRVN1.05% DURECT Corp $0.65 DRRX4.33% Pieris...

Find the latest eFFECTOR Therapeutics, Inc. (EFTR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Dec 1, 2023 · Vince Angotti. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain.

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Iterum Therapeutics PLC have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00.The reverse stock split will become effective at 5:01 p.m. ET on Tuesday, October 25, 2022. AcelRx's common stock will continue to be traded on the Nasdaq Global Market under the symbol ACRX and will begin trading on a split-adjusted basis when the market opens on Wednesday, October 26, 2022. The reverse stock split is intended to enable AcelRx ...Find the latest HighPeak Energy, Inc. (HPK) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Energizer Holdings, Inc. (ENR) stock quote, history, news and other vital information to help you with your stock trading and investing.Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

Dec 1, 2023 · 10% most volatile stocks in US Market. 15.5%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: APLD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: APLD's weekly volatility has decreased from 18% to 12% over the past year, but is still higher than 75% of US ... Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its quarterly earnings results on Thursday, November, 11th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.22. The company had revenue of $3.83 million for the quarter.AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...

Vince Angotti. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain.Nabriva Therapeutics plc (NASDAQ:NBRV) announced its quarterly earnings data on Thursday, May, 6th. The biotechnology company reported ($13.25) EPS for the quarter, beating analysts' consensus estimates of ($16.75) by $3.50. The biotechnology company earned $2.53 million during the quarter, compared to analysts' expectations of …

The 2 analysts offering 1 year price forecasts for AcelRx Pharmaceuticals, Inc. have a max estimate of 5.0000 and a min estimate of 4.2500. Analyst rating Based on 2 analysts …Forecast . Price target. 4.63 0.00 0.00%. The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to ACRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreThe sales figure was up 433% sequentially, and the total revenue figure was up 133% year-over-year.Against this backdrop, several members of the Street believe ACRX’s $1.40 share price looks ...The stock boasts 4 recent buy ratings vs just 1 hold rating. This is with an $7.75 average price target, suggesting shares could surge 113%. Get the ACRX Stock Research Report.Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 31.00, with a high estimate of 31.26 and a low estimate of 19.00. The median ...Nov 22, 2023 · ACRX has an Altman Z-Score of -27.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for AcelRx Pharmaceuticals, Inc. (ACRX) stock, including valuation metrics, financial numbers, share information and more. 14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) …Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Available stock prediction. From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock.

Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ACRX stock stock is $4.63, which predicts an increase of …

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...

ACV Auctions Inc. (ACVA) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACVA one year forecast. ACV Auctions stock monthly and weekly forecasts.Find real-time IMGN - ImmunoGen Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time CRBP - Corbus Pharmaceuticals Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.Dec 1, 2023 · A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ... Find real-time ITRM - Iterum Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business.Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers barAPLD | Complete Applied Digital Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.High Growth Earnings: ACRX is forecast to remain unprofitable over the next 3 years. Revenue vs Market : ACRX's revenue (63.5% per year) is forecast to grow …May 9, 2023 · ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ... In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its quarterly earnings results on Thursday, November, 11th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.22. The company had revenue of $3.83 million for the quarter.

Track Acelrx Pharmaceuticals Inc (ACRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Stock Price Forecast The 5 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 4.00.EPS forecast (this quarter)-$0.48: Annual revenue (last year) $1.8M: Annual profit (last year) $42.5M: Net profit margin: 2,400.62%Instagram:https://instagram. instant bank account with virtual debit cardwhich forex brokers accept us clientshighest stock todayoutster Acme United Corporation (ACU) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACU one year forecast. Acme United stock monthly and weekly forecasts.High Growth Earnings: ACRX is forecast to remain unprofitable over the next 3 years. Revenue vs Market : ACRX's revenue (63.5% per year) is forecast to grow … trading.scottrade.combest automated trading platforms Find real-time NBY - NovaBay Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. AcelRx Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ACRX updated stock price target summary. forbes best in state 2023 A stock with insider buying, one presenting data next year, and a total dog walk into a bar... I'll keep it short and sweet. New article on KPLT LPTX…What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.